Moximed said that surgeons have implanted its Calpyso knee unloading system in the first osteoarthritis patient in its U.S. clinical trial.
The Calypso is designed to work like a shock absorber for the knee by restoring a more normal load balance within the joint. It may help prevent or delay total knee replacement, according to the Fremont, Calif. company. The system is implanted under the skin, along the inside of the knee joint, through a single incision. Unlike joint replacement procedures, none of the bone, ligament, or cartilage is removed, which may help maintain future treatment options, the company said.